Stem cell therapy with light treatment for melasma
Part of Genetic & congenital, Skin clinical trials.
This trial combines a light-based device with stem cells from donated umbilical cords to treat melasma, a type of skin darkening. It may help if you have stable melasma and haven't tried laser or stem cell treatments before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 60 with melasma (dark patches on your face).
- Your melasma has been stable (not changing) for at least the last 3 months.
- You have never had stem cell therapy or laser treatment for melasma.
- You are not pregnant or breastfeeding.
- You do not have a history of allergies to medications or sensitivity to light.
- You have no serious health problems, active infections, or keloid scars.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether stem cell exosomes, combined with laser or microneedle treatments, can improve melasma (dark patches on the face). It aims to find a better way to lighten these spots.
This study tests a cream made from stem cell secretions to see if it can help reduce melasma (dark patches on the face). It may be an option for women who haven't improved with other treatments.
This trial tests a microneedling technique combined with three topical medications (metformin, tranexamic acid, and a modified Kligman's formula) to treat melasma, a common skin condition causing dark patches. The goal is to see if this approach safely and effectively reduces melasma in eligible women.
This trial tests if adding a special serum to laser treatment can better treat dark spots from acne and melasma in women with medium to dark skin tones. The serum contains ingredients that may help lighten spots and improve skin tone.
This trial tests a new way to deliver a medicine (tranexamic acid) into melasma patches using ultrasound waves. It aims to see if the ultrasound helps the medicine work better to lighten the dark spots.
This study tests a new gel (SM-030) for adults with moderate to severe melasma. If you join, you would use the gel on your face for a few months and stop other skin-lightening products, while applying the provided sunscreen every day.
Hear when a new Mesenchymal Stem Cells；Pigmentary Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.